The stock price of Sight Sciences Inc (NASDAQ: SGHT) has dropped by -12.38 compared to previous close of 3.07. Despite this, the company has seen a fall of -6.60% in its stock price over the last five trading days. globenewswire.com reported 2025-03-25 that MENLO PARK, Calif., March 25, 2025 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today announced plans to present at the 24th Annual Needham Healthcare Conference being held virtually.
Is It Worth Investing in Sight Sciences Inc (NASDAQ: SGHT) Right Now?
Additionally, the 36-month beta value for SGHT is 2.40. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 6 rating it as “hold,” and 0 rating it as “sell.”
The public float for SGHT is 28.48M and currently, short sellers hold a 5.48% ratio of that float. The average trading volume of SGHT on March 26, 2025 was 270.27K shares.
SGHT’s Market Performance
SGHT’s stock has seen a -6.60% decrease for the week, with a 9.35% rise in the past month and a -19.94% fall in the past quarter. The volatility ratio for the week is 10.54%, and the volatility levels for the past 30 days are at 10.98% for Sight Sciences Inc. The simple moving average for the past 20 days is 0.31% for SGHT’s stock, with a -45.40% simple moving average for the past 200 days.
Analysts’ Opinion of SGHT
Many brokerage firms have already submitted their reports for SGHT stocks, with UBS repeating the rating for SGHT by listing it as a “Buy.” The predicted price for SGHT in the upcoming period, according to UBS is $5.50 based on the research report published on December 06, 2024 of the previous year 2024.
Lake Street, on the other hand, stated in their research note that they expect to see SGHT reach a price target of $5, previously predicting the price at $10. The rating they have provided for SGHT stocks is “Hold” according to the report published on November 04th, 2024.
Lake Street gave a rating of “Buy” to SGHT, setting the target price at $10 in the report published on August 21st of the previous year.
SGHT Trading at -2.72% from the 50-Day Moving Average
After a stumble in the market that brought SGHT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -68.17% of loss for the given period.
Volatility was left at 10.98%, however, over the last 30 days, the volatility rate increased by 10.54%, as shares surge +8.03% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -17.23% lower at present.
During the last 5 trading sessions, SGHT fell by -6.60%, which changed the moving average for the period of 200-days by -62.38% in comparison to the 20-day moving average, which settled at $2.68. In addition, Sight Sciences Inc saw -26.10% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SGHT starting from Raheja Manohar K., who purchase 10,000 shares at the price of $2.73 back on Mar 12 ’25. After this action, Raheja Manohar K. now owns 145,000 shares of Sight Sciences Inc, valued at $27,250 using the latest closing price.
Raheja Manohar K., the EVP, Research & Development of Sight Sciences Inc, purchase 10,000 shares at $2.60 during a trade that took place back on Mar 13 ’25, which means that Raheja Manohar K. is holding 155,000 shares at $26,000 based on the most recent closing price.
Stock Fundamentals for SGHT
Current profitability levels for the company are sitting at:
- -0.63 for the present operating margin
- 0.85 for the gross margin
The net margin for Sight Sciences Inc stands at -0.64. The total capital return value is set at -0.4. Equity return is now at value -49.59, with -33.29 for asset returns.
Based on Sight Sciences Inc (SGHT), the company’s capital structure generated 0.32 points at debt to capital in total, while cash flow to debt ratio is standing at -0.55. The debt to equity ratio resting at 0.46. The interest coverage ratio of the stock is -10.84.
Currently, EBITDA for the company is -45.9 million with net debt to EBITDA at 1.68. When we switch over and look at the enterprise to sales, we see a ratio of 0.73. The receivables turnover for the company is 7.4for trailing twelve months and the total asset turnover is 0.56. The liquidity ratio also appears to be rather interesting for investors as it stands at 9.04.
Conclusion
In conclusion, Sight Sciences Inc (SGHT) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
